NK cell therapy (Natural Killer cell therapy) is a form of cellular immunotherapy that uses one of the immune system’s fastest-acting defense cells. In this approach, a patient’s own NK cells — or those from a healthy donor — are collected, multiplied and activated in a specialized laboratory, and then reintroduced to strengthen the body’s ability to recognize and target abnormal cells.
NK cell therapy is studied and applied alongside standard oncology treatments such as surgery, chemotherapy and radiotherapy — not as a replacement for them. It is a rapidly advancing area of research, and eligibility for any individual patient must be assessed on a case-by-case basis by a qualified oncology team.
At Super Healthcare In Turkey, we do not provide treatment directly. We help international patients connect with accredited Turkish medical institutions and experienced specialists who can review their case and advise on whether a cell-based immunotherapy pathway may be appropriate.
NK (Natural Killer) cells are part of the body’s innate immune system — the first line of defense.
They circulate in the blood and are found in the liver, spleen and bone marrow.
What sets NK cells apart is that, unlike T cells, they do not require prior antigen presentation (sensitization) to identify a threat. They can recognize cells that are stressed, mutated or virally infected as “non-self” and respond quickly and spontaneously. Through specialized surface receptors, NK cells distinguish healthy cells from abnormal ones and, when a threat is detected, release cytotoxic substances (perforin and granzyme) to eliminate the target cell in a controlled way.
NK cell therapies differ based on the source of the cells and how they are engineered:
Cells are collected from the patient, expanded and activated in the laboratory, then returned to the same patient. Because the patient’s own cells are used, the risk of immune mismatch is low.
Cells are sourced from healthy donors, processed and infused into the patient. Thanks to the unique biology of NK cells, this approach carries a low risk of graft-versus-host disease (GvHD) and offers “off-the-shelf” potential.
NK cells are genetically engineered to recognize cancer cells more precisely. In clinical research, CAR-NK is regarded as a potentially safer alternative to CAR-T therapy and is one of the most closely watched developments in cellular immunotherapy.
Published clinical research highlights several potential advantages of CAR-NK therapy compared with CAR-T:
Important: CAR-NK and most NK cell therapies remain largely in the early clinical-research stage and are not yet established as standard treatment for most cancers.
Turkey has become one of the world’s leading destinations for medical care, welcoming over 1.5 million international patients per year. For patients exploring advanced or specialized treatments, Turkey offers:
Super Healthcare In Turkey coordinates the full journey — from your initial enquiry to your safe return home.
1. Share your case. You complete a simple service request form with your medical history and treatment goals.
2. Case review. We forward your request to our partner medical institutions, whose specialists evaluate your suitability.
3. Personalized plan. You receive a tailored proposal outlining the recommended pathway, next steps and expectations.
4. Travel & stay. If you choose to proceed, we arrange your flights, airport transfers and accommodation in partner hotels.
5. Treatment & care. Your treatment is carried out by the medical institution under specialist supervision.
6. Return home. We coordinate your departure and support your journey back to your country.
1. Is NK cell therapy a cure for cancer?
No. NK cell therapy is not a proven cure and is not a replacement for standard oncology care. It is studied as part of a broader treatment plan, and its use is decided individually by an oncology board.
2. Is it suitable for every cancer patient?
No. Suitability depends on the cancer type, stage, overall health and response to existing treatments. Each case is reviewed individually by qualified specialists.
3. What is the current status of these therapies?
Most NK cell and CAR-NK therapies are still in clinical research or are applied under experimental or special-approval protocols. Early results in certain blood cancers are encouraging, while research in solid tumors is ongoing.
4. Does Super Healthcare In Turkey provide the treatment?
No. We are a facilitation platform. We connect international patients with accredited partner medical institutions in Turkey and coordinate travel and accommodation. All medical decisions are made by the treating institution.
5. How do I find out if I am eligible?
The first step is a free, no-obligation case review. Submit your details through our request form and our team will guide you.
If you would like to learn whether a cell-based immunotherapy pathway could be relevant for you or a loved one, our team can connect you with accredited Turkish medical institutions for an individual evaluation.
Medical Disclaimer: The information on this page is provided for general informational purposes only and does not constitute medical advice, diagnosis or treatment. NK cell and CAR-NK therapies are largely investigational and are not established as standard treatment for most cancers. They are not a substitute for conventional oncology care. Any decision regarding treatment must be made by qualified medical professionals following an individual assessment. Super Healthcare In Turkey is a healthcare facilitation platform and does not provide medical treatment directly.
